The document is a list of impurities and related compounds for various pharmaceutical products, including metoprolol, metronidazole, milnacipran, minoxidil, mirabegron, and many others. It provides the chemical names and CAS registry numbers for each impurity compound. The list is from Opulent Pharma, an Indian company that offers impurity reference standards and custom synthesis support.
OPULENT PHARMA IMPURITY STOCK LIST (S-Z & MISCELLANEOUS)Opulent Pharma
This document lists impurity stock for various pharmaceutical products, including sotalol, sparfloxacin, stavudine, strontium ranelate, sulbactam, sulfadiazine, sulfadimidine, sulfamethoxazole, sulfasalazine, sulindac, sultamicillin, sumatriptan, sunitinib, tadalafil, tamsulosin, tasimelteon, telmisartan, temozolomide, and teneligliptin. For each product, several related impurities are listed along with their CAS numbers if available. Contact information is provided for inquiries.
OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
OPULENT PHARMA IMPURITY STOCK LIST (COMPLETE)Opulent Pharma
OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
2024 State of Marketing Report – by HubspotMarius Sescu
https://www.hubspot.com/state-of-marketing
· Scaling relationships and proving ROI
· Social media is the place for search, sales, and service
· Authentic influencer partnerships fuel brand growth
· The strongest connections happen via call, click, chat, and camera.
· Time saved with AI leads to more creative work
· Seeking: A single source of truth
· TLDR; Get on social, try AI, and align your systems.
· More human marketing, powered by robots
ChatGPT is a revolutionary addition to the world since its introduction in 2022. A big shift in the sector of information gathering and processing happened because of this chatbot. What is the story of ChatGPT? How is the bot responding to prompts and generating contents? Swipe through these slides prepared by Expeed Software, a web development company regarding the development and technical intricacies of ChatGPT!
Product Design Trends in 2024 | Teenage EngineeringsPixeldarts
The realm of product design is a constantly changing environment where technology and style intersect. Every year introduces fresh challenges and exciting trends that mold the future of this captivating art form. In this piece, we delve into the significant trends set to influence the look and functionality of product design in the year 2024.
How Race, Age and Gender Shape Attitudes Towards Mental HealthThinkNow
Mental health has been in the news quite a bit lately. Dozens of U.S. states are currently suing Meta for contributing to the youth mental health crisis by inserting addictive features into their products, while the U.S. Surgeon General is touring the nation to bring awareness to the growing epidemic of loneliness and isolation. The country has endured periods of low national morale, such as in the 1970s when high inflation and the energy crisis worsened public sentiment following the Vietnam War. The current mood, however, feels different. Gallup recently reported that national mental health is at an all-time low, with few bright spots to lift spirits.
To better understand how Americans are feeling and their attitudes towards mental health in general, ThinkNow conducted a nationally representative quantitative survey of 1,500 respondents and found some interesting differences among ethnic, age and gender groups.
Technology
For example, 52% agree that technology and social media have a negative impact on mental health, but when broken out by race, 61% of Whites felt technology had a negative effect, and only 48% of Hispanics thought it did.
While technology has helped us keep in touch with friends and family in faraway places, it appears to have degraded our ability to connect in person. Staying connected online is a double-edged sword since the same news feed that brings us pictures of the grandkids and fluffy kittens also feeds us news about the wars in Israel and Ukraine, the dysfunction in Washington, the latest mass shooting and the climate crisis.
Hispanics may have a built-in defense against the isolation technology breeds, owing to their large, multigenerational households, strong social support systems, and tendency to use social media to stay connected with relatives abroad.
Age and Gender
When asked how individuals rate their mental health, men rate it higher than women by 11 percentage points, and Baby Boomers rank it highest at 83%, saying it’s good or excellent vs. 57% of Gen Z saying the same.
Gen Z spends the most amount of time on social media, so the notion that social media negatively affects mental health appears to be correlated. Unfortunately, Gen Z is also the generation that’s least comfortable discussing mental health concerns with healthcare professionals. Only 40% of them state they’re comfortable discussing their issues with a professional compared to 60% of Millennials and 65% of Boomers.
Race Affects Attitudes
As seen in previous research conducted by ThinkNow, Asian Americans lag other groups when it comes to awareness of mental health issues. Twenty-four percent of Asian Americans believe that having a mental health issue is a sign of weakness compared to the 16% average for all groups. Asians are also considerably less likely to be aware of mental health services in their communities (42% vs. 55%) and most likely to seek out information on social media (51% vs. 35%).
AI Trends in Creative Operations 2024 by Artwork Flow.pdfmarketingartwork
Creative operations teams expect increased AI use in 2024. Currently, over half of tasks are not AI-enabled, but this is expected to decrease in the coming year. ChatGPT is the most popular AI tool currently. Business leaders are more actively exploring AI benefits than individual contributors. Most respondents do not believe AI will impact workforce size in 2024. However, some inhibitions still exist around AI accuracy and lack of understanding. Creatives primarily want to use AI to save time on mundane tasks and boost productivity.
OPULENT PHARMA IMPURITY STOCK LIST (S-Z & MISCELLANEOUS)Opulent Pharma
This document lists impurity stock for various pharmaceutical products, including sotalol, sparfloxacin, stavudine, strontium ranelate, sulbactam, sulfadiazine, sulfadimidine, sulfamethoxazole, sulfasalazine, sulindac, sultamicillin, sumatriptan, sunitinib, tadalafil, tamsulosin, tasimelteon, telmisartan, temozolomide, and teneligliptin. For each product, several related impurities are listed along with their CAS numbers if available. Contact information is provided for inquiries.
OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
OPULENT PHARMA IMPURITY STOCK LIST (COMPLETE)Opulent Pharma
OPULENT PHARMA specialize in key areas like Organic Custom Synthesis & Chemical Development, and can offer chemical synthesis services of desired compounds from milligram to kg level. We are strong and currently focused in Pharmaceutical Impurity Synthesis but we also provide synthesis support for API, Pharmaceutical Intermediates, Specialty & Research Chemicals, Building Blocks & Library Synthesis, Custom Synthesis. We can offer more than 4000 Impurities (LIST ENCLOSED) from STOCK at an very competitive price, also feel free to share other requirements as the products we can offer are not limited to the list.
2024 State of Marketing Report – by HubspotMarius Sescu
https://www.hubspot.com/state-of-marketing
· Scaling relationships and proving ROI
· Social media is the place for search, sales, and service
· Authentic influencer partnerships fuel brand growth
· The strongest connections happen via call, click, chat, and camera.
· Time saved with AI leads to more creative work
· Seeking: A single source of truth
· TLDR; Get on social, try AI, and align your systems.
· More human marketing, powered by robots
ChatGPT is a revolutionary addition to the world since its introduction in 2022. A big shift in the sector of information gathering and processing happened because of this chatbot. What is the story of ChatGPT? How is the bot responding to prompts and generating contents? Swipe through these slides prepared by Expeed Software, a web development company regarding the development and technical intricacies of ChatGPT!
Product Design Trends in 2024 | Teenage EngineeringsPixeldarts
The realm of product design is a constantly changing environment where technology and style intersect. Every year introduces fresh challenges and exciting trends that mold the future of this captivating art form. In this piece, we delve into the significant trends set to influence the look and functionality of product design in the year 2024.
How Race, Age and Gender Shape Attitudes Towards Mental HealthThinkNow
Mental health has been in the news quite a bit lately. Dozens of U.S. states are currently suing Meta for contributing to the youth mental health crisis by inserting addictive features into their products, while the U.S. Surgeon General is touring the nation to bring awareness to the growing epidemic of loneliness and isolation. The country has endured periods of low national morale, such as in the 1970s when high inflation and the energy crisis worsened public sentiment following the Vietnam War. The current mood, however, feels different. Gallup recently reported that national mental health is at an all-time low, with few bright spots to lift spirits.
To better understand how Americans are feeling and their attitudes towards mental health in general, ThinkNow conducted a nationally representative quantitative survey of 1,500 respondents and found some interesting differences among ethnic, age and gender groups.
Technology
For example, 52% agree that technology and social media have a negative impact on mental health, but when broken out by race, 61% of Whites felt technology had a negative effect, and only 48% of Hispanics thought it did.
While technology has helped us keep in touch with friends and family in faraway places, it appears to have degraded our ability to connect in person. Staying connected online is a double-edged sword since the same news feed that brings us pictures of the grandkids and fluffy kittens also feeds us news about the wars in Israel and Ukraine, the dysfunction in Washington, the latest mass shooting and the climate crisis.
Hispanics may have a built-in defense against the isolation technology breeds, owing to their large, multigenerational households, strong social support systems, and tendency to use social media to stay connected with relatives abroad.
Age and Gender
When asked how individuals rate their mental health, men rate it higher than women by 11 percentage points, and Baby Boomers rank it highest at 83%, saying it’s good or excellent vs. 57% of Gen Z saying the same.
Gen Z spends the most amount of time on social media, so the notion that social media negatively affects mental health appears to be correlated. Unfortunately, Gen Z is also the generation that’s least comfortable discussing mental health concerns with healthcare professionals. Only 40% of them state they’re comfortable discussing their issues with a professional compared to 60% of Millennials and 65% of Boomers.
Race Affects Attitudes
As seen in previous research conducted by ThinkNow, Asian Americans lag other groups when it comes to awareness of mental health issues. Twenty-four percent of Asian Americans believe that having a mental health issue is a sign of weakness compared to the 16% average for all groups. Asians are also considerably less likely to be aware of mental health services in their communities (42% vs. 55%) and most likely to seek out information on social media (51% vs. 35%).
AI Trends in Creative Operations 2024 by Artwork Flow.pdfmarketingartwork
Creative operations teams expect increased AI use in 2024. Currently, over half of tasks are not AI-enabled, but this is expected to decrease in the coming year. ChatGPT is the most popular AI tool currently. Business leaders are more actively exploring AI benefits than individual contributors. Most respondents do not believe AI will impact workforce size in 2024. However, some inhibitions still exist around AI accuracy and lack of understanding. Creatives primarily want to use AI to save time on mundane tasks and boost productivity.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Organizational culture includes values, norms, systems, symbols, language, assumptions, beliefs, and habits that influence employee behaviors and how people interpret those behaviors. It is important because culture can help or hinder a company's success. Some key aspects of Netflix's culture that help it achieve results include hiring smartly so every position has stars, focusing on attitude over just aptitude, and having a strict policy against peacocks, whiners, and jerks.
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
PepsiCo provided a safe harbor statement noting that any forward-looking statements are based on currently available information and are subject to risks and uncertainties. It also provided information on non-GAAP measures and directing readers to its website for disclosure and reconciliation. The document then discussed PepsiCo's business overview, including that it is a global beverage and convenient food company with iconic brands, $91 billion in net revenue in 2023, and nearly $14 billion in core operating profit. It operates through a divisional structure with a focus on local consumers.
Histololgy of Female Reproductive System.pptxAyeshaZaid1
Dive into an in-depth exploration of the histological structure of female reproductive system with this comprehensive lecture. Presented by Dr. Ayesha Irfan, Assistant Professor of Anatomy, this presentation covers the Gross anatomy and functional histology of the female reproductive organs. Ideal for students, educators, and anyone interested in medical science, this lecture provides clear explanations, detailed diagrams, and valuable insights into female reproductive system. Enhance your knowledge and understanding of this essential aspect of human biology.
- Video recording of this lecture in English language: https://youtu.be/Pt1nA32sdHQ
- Video recording of this lecture in Arabic language: https://youtu.be/uFdc9F0rlP0
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The skin is the largest organ and its health plays a vital role among the other sense organs. The skin concerns like acne breakout, psoriasis, or anything similar along the lines, finding a qualified and experienced dermatologist becomes paramount.
Discover the benefits of homeopathic medicine for irregular periods with our guide on 5 common remedies. Learn how these natural treatments can help regulate menstrual cycles and improve overall menstrual health.
Visit Us: https://drdeepikashomeopathy.com/service/irregular-periods-treatment/
Summer is a time for fun in the sun, but the heat and humidity can also wreak havoc on your skin. From itchy rashes to unwanted pigmentation, several skin conditions become more prevalent during these warmer months.
Giloy in Ayurveda - Classical Categorization and SynonymsPlanet Ayurveda
Giloy, also known as Guduchi or Amrita in classical Ayurvedic texts, is a revered herb renowned for its myriad health benefits. It is categorized as a Rasayana, meaning it has rejuvenating properties that enhance vitality and longevity. Giloy is celebrated for its ability to boost the immune system, detoxify the body, and promote overall wellness. Its anti-inflammatory, antipyretic, and antioxidant properties make it a staple in managing conditions like fever, diabetes, and stress. The versatility and efficacy of Giloy in supporting health naturally highlight its importance in Ayurveda. At Planet Ayurveda, we provide a comprehensive range of health services and 100% herbal supplements that harness the power of natural ingredients like Giloy. Our products are globally available and affordable, ensuring that everyone can benefit from the ancient wisdom of Ayurveda. If you or your loved ones are dealing with health issues, contact Planet Ayurveda at 01725214040 to book an online video consultation with our professional doctors. Let us help you achieve optimal health and wellness naturally.
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Osvaldo Bernardo Muchanga-GASTROINTESTINAL INFECTIONS AND GASTRITIS-2024.pdfOsvaldo Bernardo Muchanga
GASTROINTESTINAL INFECTIONS AND GASTRITIS
Osvaldo Bernardo Muchanga
Gastrointestinal Infections
GASTROINTESTINAL INFECTIONS result from the ingestion of pathogens that cause infections at the level of this tract, generally being transmitted by food, water and hands contaminated by microorganisms such as E. coli, Salmonella, Shigella, Vibrio cholerae, Campylobacter, Staphylococcus, Rotavirus among others that are generally contained in feces, thus configuring a FECAL-ORAL type of transmission.
Among the factors that lead to the occurrence of gastrointestinal infections are the hygienic and sanitary deficiencies that characterize our markets and other places where raw or cooked food is sold, poor environmental sanitation in communities, deficiencies in water treatment (or in the process of its plumbing), risky hygienic-sanitary habits (not washing hands after major and/or minor needs), among others.
These are generally consequences (signs and symptoms) resulting from gastrointestinal infections: diarrhea, vomiting, fever and malaise, among others.
The treatment consists of replacing lost liquids and electrolytes (drinking drinking water and other recommended liquids, including consumption of juicy fruits such as papayas, apples, pears, among others that contain water in their composition).
To prevent this, it is necessary to promote health education, improve the hygienic-sanitary conditions of markets and communities in general as a way of promoting, preserving and prolonging PUBLIC HEALTH.
Gastritis and Gastric Health
Gastric Health is one of the most relevant concerns in human health, with gastrointestinal infections being among the main illnesses that affect humans.
Among gastric problems, we have GASTRITIS AND GASTRIC ULCERS as the main public health problems. Gastritis and gastric ulcers normally result from inflammation and corrosion of the walls of the stomach (gastric mucosa) and are generally associated (caused) by the bacterium Helicobacter pylor, which, according to the literature, this bacterium settles on these walls (of the stomach) and starts to release urease that ends up altering the normal pH of the stomach (acid), which leads to inflammation and corrosion of the mucous membranes and consequent gastritis or ulcers, respectively.
In addition to bacterial infections, gastritis and gastric ulcers are associated with several factors, with emphasis on prolonged fasting, chemical substances including drugs, alcohol, foods with strong seasonings including chilli, which ends up causing inflammation of the stomach walls and/or corrosion. of the same, resulting in the appearance of wounds and consequent gastritis or ulcers, respectively.
Among patients with gastritis and/or ulcers, one of the dilemmas is associated with the foods to consume in order to minimize the sensation of pain and discomfort.
Travel Clinic Cardiff: Health Advice for International TravelersNX Healthcare
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
Organizational culture includes values, norms, systems, symbols, language, assumptions, beliefs, and habits that influence employee behaviors and how people interpret those behaviors. It is important because culture can help or hinder a company's success. Some key aspects of Netflix's culture that help it achieve results include hiring smartly so every position has stars, focusing on attitude over just aptitude, and having a strict policy against peacocks, whiners, and jerks.
PEPSICO Presentation to CAGNY Conference Feb 2024Neil Kimberley
PepsiCo provided a safe harbor statement noting that any forward-looking statements are based on currently available information and are subject to risks and uncertainties. It also provided information on non-GAAP measures and directing readers to its website for disclosure and reconciliation. The document then discussed PepsiCo's business overview, including that it is a global beverage and convenient food company with iconic brands, $91 billion in net revenue in 2023, and nearly $14 billion in core operating profit. It operates through a divisional structure with a focus on local consumers.
Content Methodology: A Best Practices Report (Webinar)contently
This document provides an overview of content methodology best practices. It defines content methodology as establishing objectives, KPIs, and a culture of continuous learning and iteration. An effective methodology focuses on connecting with audiences, creating optimal content, and optimizing processes. It also discusses why a methodology is needed due to the competitive landscape, proliferation of channels, and opportunities for improvement. Components of an effective methodology include defining objectives and KPIs, audience analysis, identifying opportunities, and evaluating resources. The document concludes with recommendations around creating a content plan, testing and optimizing content over 90 days.
How to Prepare For a Successful Job Search for 2024Albert Qian
The document provides guidance on preparing a job search for 2024. It discusses the state of the job market, focusing on growth in AI and healthcare but also continued layoffs. It recommends figuring out what you want to do by researching interests and skills, then conducting informational interviews. The job search should involve building a personal brand on LinkedIn, actively applying to jobs, tailoring resumes and interviews, maintaining job hunting as a habit, and continuing self-improvement. Once hired, the document advises setting new goals and keeping skills and networking active in case of future opportunities.
A report by thenetworkone and Kurio.
The contributing experts and agencies are (in an alphabetical order): Sylwia Rytel, Social Media Supervisor, 180heartbeats + JUNG v MATT (PL), Sharlene Jenner, Vice President - Director of Engagement Strategy, Abelson Taylor (USA), Alex Casanovas, Digital Director, Atrevia (ES), Dora Beilin, Senior Social Strategist, Barrett Hoffher (USA), Min Seo, Campaign Director, Brand New Agency (KR), Deshé M. Gully, Associate Strategist, Day One Agency (USA), Francesca Trevisan, Strategist, Different (IT), Trevor Crossman, CX and Digital Transformation Director; Olivia Hussey, Strategic Planner; Simi Srinarula, Social Media Manager, The Hallway (AUS), James Hebbert, Managing Director, Hylink (CN / UK), Mundy Álvarez, Planning Director; Pedro Rojas, Social Media Manager; Pancho González, CCO, Inbrax (CH), Oana Oprea, Head of Digital Planning, Jam Session Agency (RO), Amy Bottrill, Social Account Director, Launch (UK), Gaby Arriaga, Founder, Leonardo1452 (MX), Shantesh S Row, Creative Director, Liwa (UAE), Rajesh Mehta, Chief Strategy Officer; Dhruv Gaur, Digital Planning Lead; Leonie Mergulhao, Account Supervisor - Social Media & PR, Medulla (IN), Aurelija Plioplytė, Head of Digital & Social, Not Perfect (LI), Daiana Khaidargaliyeva, Account Manager, Osaka Labs (UK / USA), Stefanie Söhnchen, Vice President Digital, PIABO Communications (DE), Elisabeth Winiartati, Managing Consultant, Head of Global Integrated Communications; Lydia Aprina, Account Manager, Integrated Marketing and Communications; Nita Prabowo, Account Manager, Integrated Marketing and Communications; Okhi, Web Developer, PNTR Group (ID), Kei Obusan, Insights Director; Daffi Ranandi, Insights Manager, Radarr (SG), Gautam Reghunath, Co-founder & CEO, Talented (IN), Donagh Humphreys, Head of Social and Digital Innovation, THINKHOUSE (IRE), Sarah Yim, Strategy Director, Zulu Alpha Kilo (CA).
Trends In Paid Search: Navigating The Digital Landscape In 2024Search Engine Journal
The search marketing landscape is evolving rapidly with new technologies, and professionals, like you, rely on innovative paid search strategies to meet changing demands.
It’s important that you’re ready to implement new strategies in 2024.
Check this out and learn the top trends in paid search advertising that are expected to gain traction, so you can drive higher ROI more efficiently in 2024.
You’ll learn:
- The latest trends in AI and automation, and what this means for an evolving paid search ecosystem.
- New developments in privacy and data regulation.
- Emerging ad formats that are expected to make an impact next year.
Watch Sreekant Lanka from iQuanti and Irina Klein from OneMain Financial as they dive into the future of paid search and explore the trends, strategies, and technologies that will shape the search marketing landscape.
If you’re looking to assess your paid search strategy and design an industry-aligned plan for 2024, then this webinar is for you.
5 Public speaking tips from TED - Visualized summarySpeakerHub
From their humble beginnings in 1984, TED has grown into the world’s most powerful amplifier for speakers and thought-leaders to share their ideas. They have over 2,400 filmed talks (not including the 30,000+ TEDx videos) freely available online, and have hosted over 17,500 events around the world.
With over one billion views in a year, it’s no wonder that so many speakers are looking to TED for ideas on how to share their message more effectively.
The article “5 Public-Speaking Tips TED Gives Its Speakers”, by Carmine Gallo for Forbes, gives speakers five practical ways to connect with their audience, and effectively share their ideas on stage.
Whether you are gearing up to get on a TED stage yourself, or just want to master the skills that so many of their speakers possess, these tips and quotes from Chris Anderson, the TED Talks Curator, will encourage you to make the most impactful impression on your audience.
See the full article and more summaries like this on SpeakerHub here: https://speakerhub.com/blog/5-presentation-tips-ted-gives-its-speakers
See the original article on Forbes here:
http://www.forbes.com/forbes/welcome/?toURL=http://www.forbes.com/sites/carminegallo/2016/05/06/5-public-speaking-tips-ted-gives-its-speakers/&refURL=&referrer=#5c07a8221d9b
ChatGPT and the Future of Work - Clark Boyd Clark Boyd
Everyone is in agreement that ChatGPT (and other generative AI tools) will shape the future of work. Yet there is little consensus on exactly how, when, and to what extent this technology will change our world.
Businesses that extract maximum value from ChatGPT will use it as a collaborative tool for everything from brainstorming to technical maintenance.
For individuals, now is the time to pinpoint the skills the future professional will need to thrive in the AI age.
Check out this presentation to understand what ChatGPT is, how it will shape the future of work, and how you can prepare to take advantage.
The document provides career advice for getting into the tech field, including:
- Doing projects and internships in college to build a portfolio.
- Learning about different roles and technologies through industry research.
- Contributing to open source projects to build experience and network.
- Developing a personal brand through a website and social media presence.
- Networking through events, communities, and finding a mentor.
- Practicing interviews through mock interviews and whiteboarding coding questions.
Google's Just Not That Into You: Understanding Core Updates & Search IntentLily Ray
1. Core updates from Google periodically change how its algorithms assess and rank websites and pages. This can impact rankings through shifts in user intent, site quality issues being caught up to, world events influencing queries, and overhauls to search like the E-A-T framework.
2. There are many possible user intents beyond just transactional, navigational and informational. Identifying intent shifts is important during core updates. Sites may need to optimize for new intents through different content types and sections.
3. Responding effectively to core updates requires analyzing "before and after" data to understand changes, identifying new intents or page types, and ensuring content matches appropriate intents across video, images, knowledge graphs and more.
A brief introduction to DataScience with explaining of the concepts, algorithms, machine learning, supervised and unsupervised learning, clustering, statistics, data preprocessing, real-world applications etc.
It's part of a Data Science Corner Campaign where I will be discussing the fundamentals of DataScience, AIML, Statistics etc.
Time Management & Productivity - Best PracticesVit Horky
Here's my presentation on by proven best practices how to manage your work time effectively and how to improve your productivity. It includes practical tips and how to use tools such as Slack, Google Apps, Hubspot, Google Calendar, Gmail and others.
The six step guide to practical project managementMindGenius
The six step guide to practical project management
If you think managing projects is too difficult, think again.
We’ve stripped back project management processes to the
basics – to make it quicker and easier, without sacrificing
the vital ingredients for success.
“If you’re looking for some real-world guidance, then The Six Step Guide to Practical Project Management will help.”
Dr Andrew Makar, Tactical Project Management
Unlocking the Power of ChatGPT and AI in Testing - A Real-World Look, present...Applitools
During this webinar, Anand Bagmar demonstrates how AI tools such as ChatGPT can be applied to various stages of the software development life cycle (SDLC) using an eCommerce application case study. Find the on-demand recording and more info at https://applitools.info/b59
Key takeaways:
• Learn how to use ChatGPT to add AI power to your testing and test automation
• Understand the limitations of the technology and where human expertise is crucial
• Gain insight into different AI-based tools
• Adopt AI-based tools to stay relevant and optimize work for developers and testers
* ChatGPT and OpenAI belong to OpenAI, L.L.C.
The document discusses various AI tools from OpenAI like GPT-3 and DALL-E 2, as well as ChatGPT. It explores how search engines are using AI and things to consider around AI-generated content. Potential SEO uses of ChatGPT are also presented, such as generating content at scale, conducting topic research, and automating basic coding tasks. The document encourages further reading on using ChatGPT for SEO purposes.
More than Just Lines on a Map: Best Practices for U.S Bike Routes
This session highlights best practices and lessons learned for U.S. Bike Route System designation, as well as how and why these routes should be integrated into bicycle planning at the local and regional level.
Presenters:
Presenter: Kevin Luecke Toole Design Group
Co-Presenter: Virginia Sullivan Adventure Cycling Association
Ride the Storm: Navigating Through Unstable Periods / Katerina Rudko (Belka G...DevGAMM Conference
Has your project been caught in a storm of deadlines, clashing requirements, and the need to change course halfway through? If yes, then check out how the administration team navigated through all of this, relocating 160 people from 3 countries and opening 2 offices during the most turbulent time in the last 20 years. Belka Games’ Chief Administrative Officer, Katerina Rudko, will share universal approaches and life hacks that can help your project survive unstable periods when there seem to be too many tasks and a lack of time and people.
2.
1‐Methoxy‐2‐(4‐nitrophenyl)ethane 69628‐98‐4
4‐(2‐Methoxyethyl)aniline 84803‐56‐5
Metoprolol Acid Ethyl Ester 29112‐40‐1
Metoprolol Acid Methyl Ester
29121‐23‐1
83281‐59‐8
Metoprolol Epoxy Ester Impurity 76805‐25‐9
Metoprolol Hydroxy Ester Impurity 17138‐28‐2
Metoprolol R‐Isomer 81024‐43‐3
Metoprolol S‐Isomer 81024‐42‐2
Product: METRONIDAZOLE IMPURITIES
Metronidazole EP impurity A (Tinidazole EP Impurity A/ Tinidazole Related Compound A/ Ornidazole Impurity 1) 696‐23‐1
Metronidazole EP Impurity C 5006‐69‐9
Metronidazole EP Impurity F (O‐Hydroxyethyl Metronidazole) 16156‐94‐8
Metronidazole EP Impurity G (Metronidazole Acetic Acid) 1010‐93‐1
Metronidazole Benzoate EP Impurity A 443‐48‐1
Metronidazole Benzoate EP Impurity C (Mefenamic Acid EP Impurity D/ Tiaprofenic Acid EP Impurity D/ Glycopyrrolate
EP Impurity D) 65‐85‐0
Product: MEXILETINE IMPURITIES
Mexiletine EP Impurity A 576‐26‐1
Product: MICONAZOLE IMPURITIES
Miconazole EP Impurity A (Econazole EP Impurity A/ Econazole Related Compound A/ Fenticonazole EP Impurity A/
Deschlorobenzyl Econazole/ Tioconazole EP Impurity D/ Isoconazole EP Impurity B/ Isoconazole Nitrate EP Impurity A) 24155‐42‐8
Miconazole Nitrate EP Impurity F
47447‐55‐2
27220‐35‐5
Miconazole EP Impurity G 909277‐71‐0
1‐(2,4‐dichlorobenzoylmethyl)imidazol 46503‐52‐0
Product: MILNACIPRAN IMPURITIES
N,N‐Diethyl‐2‐(hydroxymethyl)‐1‐phenyl‐cyclopropanecarboxamide 172016‐06‐7
N‐Methylphthalimide 550‐44‐7
Milnacipran Dimer Impurity
Product: MINOXIDIL IMPURITIES
3.
Minoxidil EP Impurity B 156‐83‐2
Minoxidil EP Impurity E/ Minoxidil Related Compound E (Deoxy Minoxidil/ Desoxyminoxidil) 24867‐26‐3
Product: MIRABEGRON IMPURITIES
Mirabegron Impurity 30 83303‐98‐4
Mirabegron Impurity 35 223673‐34‐5
Mirabegron Impurity 6/ Mirabegron Intermediate Impurity ((R)‐2‐((4‐Aminophenethyl)amino)‐1‐phenylethanol) 391901‐45‐4
(R)‐2‐((4‐aminophenethyl) amino)‐1‐phenylethanol hydrochloride 521284‐19‐5
2‐Formamidothiazol‐4‐acetic acid 75890‐68‐5
D‐Mandelic Acid (Sertraline EP Impurity E/ (R)‐(‐)‐Mandelic Acid) 611‐71‐2
L‐Mandelic Acid (Atomoxetine EP Impurity E/ (S)‐(+)‐Mandelic Acid) 17199‐29‐0
Mirabegron 2‐Nitrobenzeneethanamine Impurity 861337‐74‐8
Mirabegron 3‐Nitrobenzeneethanamine Impurity 19008‐62‐9
Mirabegron ATAA Impurity 29676‐71‐9
Mirabegron (S)‐Isomer 1796931‐48‐0
4‐(2‐(phenethylamino)ethyl)aniline 1581285‐26‐8
Product: MIRTAZAPINE IMPURITIES
Mirtazapine EP Impurity A/ Mirtazapine Related Compound B (Mirtazapine N‐Oxide) 155172‐12‐6
Mirtazapine EP Impurity B 61337‐89‐1
Mirtazapine EP Impurity E 191546‐94‐8
Mirtazapine Carboxylic Acid 61338‐13‐4
Mirtazapine Cyano Impurity 61337‐88‐0
Product: MISOPROSTOL IMPURITIES
Misoprostol EP Impurity A
Misoprostol EP Impurity B
Misoprostol EP Impurity C 58682‐86‐3
Misoprostol EP Impurity D (rac‐11‐Deoxy‐8(12)‐dehydro Misoprostol) 1331639‐92‐9
Misoprostol EP Impurity E 58717‐36‐5
Misoprostol EP Impurity F 40098‐26‐8
Misoprostol Acid 112137‐89‐0
8‐epi Misoprostol
4.
A‐type Misoprostol
B‐type Misoprostol
Bimatoprost 155206‐00‐1
Misoprostol 59122‐46‐2
Product: MODAFINIL IMPURITIES
Modafinil EP Impurity B (Modafinil sulfone) 118779‐53‐6
Product: MOMETASONE FUROATE IMPURITIES
Mometasone Furoate EP Impurity L (Dexamethasone EP Impurity D) 24916‐90‐3
Mometasone EP Impurity G 105102‐22‐5
Product: MONTELUKAST IMPURITIES
Montelukast EP Impurity A (Montelukast (S)‐Isomer)
220927‐27‐5
190078‐45‐6
Montelukast EP Impurity B/ Montelukast Related Compound F (Montelukast Methylstyrene) 918972‐54‐0
Montelukast EP Impurity C/ Montelukast Related Compound A (Montelukast Sulfoxide) 909849‐96‐3
Montelukast EP Impurity D/ Montelukast Related Compound C (Montelukast Michael Adduct (R,R)‐Isomer/ Montelukast
Bis‐Sulfide (Mixture of Diastereomers)) 1187586‐61‐3
Montelukast EP Impurity E/ Montelukast Related Compound D (Michael Adduct (R,S)‐Isomer) 1187586‐58‐8
Montelukast EP Impurity D & E (Michael Adduct (R,R)‐Isomer & (R,S)‐Isomer)
1187586‐61‐3
1242260‐05‐4
1187586‐58‐8
Montelukast EP Impurity F/ Montelukast Related Compound E (Montelukast Methylketone) 937275‐23‐5
Montelukast EP Impurity G/ Montelukast Related Compund B (Montelukast cis‐Isomer) 774538‐96‐4
Montelukast EP Impurity H (Montelukast Methoxycarbonyl Analog) 851755‐56‐1
Montelukast Intermediate Impurity‐1 120578‐03‐2
Montelukast Intermediate Impurity‐2 149968‐10‐5
Montelukast (3R)‐Hydroxy Propanol 150026‐75‐8
Montelukast (3S)‐Hydroxy Benzoate 142569‐69‐5
Montelukast 3‐Oxo Benzoate 149968‐11‐6
5.
Montelukast Dihydro Impurity
142147‐67‐9
142147‐98‐6
Montelukast Nitrile Impurity (Montelukast Cyclopropaneacetonitrile) 866923‐62‐8
Montelukast Amide (Montelukast cyclopropane acetamide) 866923‐63‐9
Montelukast Sulfone 1266620‐74‐9
Montelukast Cyclized Ether impurity
168214‐67‐3
1040351‐42‐5
1187586‐88‐4
Montelukast (3S)‐Hydroxy Propanol 287930‐77‐2
Montelukast Ketone Impurity (Montelukast 3‐Oxo Propanol Impurity) 1258428‐71‐5
Montelukast Methyl Ester 855473‐51‐7
Montelukast Racemic Diol 142569‐70‐8
Montelukast Acid 158966‐92‐8
Montelukast Dicyclohexylamine/ Montelukast DCHA 577953‐88‐9
Montelukast (3S)‐Hydroxy Methylketone 184764‐13‐4
Product: MOSAPRIDE IMPURITIES
Mosapride N‐Oxide 1161443‐73‐7
2‐Aminomethyl‐4‐(4‐fluorobenzyl)morpholine 112914‐13‐3
Des‐4‐fluorobenzyl Mosapride 152013‐26‐8
Product: MOXIFLOXACIN IMPURITIES
Moxifloxacin EP Impurity A/ Moxifloxacin Related Compound A (Moxifloxacin Difluoro Analog) 151213‐15‐9
Moxifloxacin EP Impurity B (Moxifloxacin Dimethoxy Analog) 1029364‐73‐5
Moxifloxacin EP Impurity C (Moxifloxacin Ethyl Analog) 1029364‐75‐7
Moxifloxacin EP Impurity D (Moxifloxacin Isomer) 1029364‐77‐9
Moxifloxacin EP Impurity E (Moxifloxacin O‐Desmethyl Analog)
721970‐36‐1
1292904‐74‐5
Moxifloxacin EP Impurity F (Moxifloxacin Methyl Ester) 721970‐35‐0
Moxifloxacin N‐Methyl Analog
721970‐37‐2
1350716‐67‐4
6.
Moxifloxacin (R,R)‐Isomer
268545‐13‐7
1346603‐25‐5
Moxifloxacin Difluoro Hydroxy Acid Impurity (Gatifloxacin Related Compound B) 154093‐72‐8
1‐Methylpiperazine (Imatinib EP Impurity G/ Cyclizine impurity A/ Cyclizine Related Compound A)
109‐01‐3
34352‐59‐5
Moxifloxacin Difluoro Methyl Ester Impurity 141290‐02‐0
6‐Benzyl‐5,7‐dihydro‐5,7‐dioxopyrrolo[3,4‐b]pyridine 18184‐75‐3
Moxifloxacin Trifluoro Acid Impurity 94695‐52‐0
Moxifloxacin Difluoro Methoxy Ethyl Ester 112811‐71‐9
Moxifloxacin 7‐Amino Impurity 172426‐88‐9
Moxifloxacin Decarboxy Analog 1322062‐57‐6
Product: MYCOPHENOLATE MOFETIL IMPURITIES
Mycophenolate Mofetil EP Impurity B 1094322‐91‐4
Mycophenolate Mofetil EP Impurity D (O‐Methyl Mycophenolate Mofetil) 1322681‐37‐7
Mycophenolate Mofetil EP Impurity E (Mycophenolic Acid Methyl Ester) 31858‐66‐9
Mycophenolate Mofetil EP Impurity F (Mycophenolic Acid) 24280‐93‐1
Mycophenolate Mofetil EP Impurity G (Mycophenolate Mofetil N‐Oxide) 224052‐51‐1
Mycophenolate Mofetil EP Impurity H/ Mycophenolate Mofetil Related Compound B (Mycophenolic Lactone)
26675‐76‐3
79081‐87‐1
Product: NABUMETONE IMPURITIES
Nabumetone EP Impurity F 29619‐45‐2
Product: NADOLOL IMPURITIES
Nadolol EP Impurity A/ Nadolol alcohol
Nadolol EP Impurity B/ Nadolol Methoxy analog
Nadolol EP Impurity C/ Diaryl glycerol analog
Nadolol EP Impurity D/ Nadolol dimer 67247‐26‐1
Nadolol EP Impurity E 67247‐33‐0
Nadolol EP Impurity F/ Naphthyl analog 2116‐22‐5
Nadolol EP Impurity G/ Dideoxy Nadolol 33841‐03‐1
Product: NALBUPHINE IMPURITIES
7.
2,2‐Bis Nalbuphine 214542‐42‐4
6‐Keto Nalbuphine 16676‐33‐8
Product: NALIDIXIC ACID IMPURITIES
Nalidixic Acid EP Impurity C 87‐13‐8
Product: NALTREXONE IMPURITIES
2‐Hydroxy‐3‐O‐methylnaltrexone 67829‐18‐9
10‐Oxo Naltrexone 96445‐13‐5
Product: NAPHAZOLINE IMPURITIES
Naphazoline EP Impurity A 36321‐43‐4
Product: NAPROXEN IMPURITIES
Naproxen EP Impurity A ((S)‐6‐Demethylnaproxen) 52079‐10‐4
Naproxen EP Impurity B 89617‐86‐7
Naproxen EP Impurity C ((S)‐5‐Bromo Naproxen/ (+)‐Bromonaproxen) 84236‐26‐0
Naproxen EP Impurity D 116883‐62‐6
Naproxen EP Impurity E 26159‐35‐3
Naproxen EP Impurity F 31220‐35‐6
Naproxen EP Impurity G/ Naproxen Related Compound G (Naproxen R‐Isomer) 23979‐41‐1
Naproxen EP Impurity H 5111‐66‐0
Naproxen EP Impurity I (Desmethyl Naproxen) 23981‐47‐7
Naproxen EP Impurity J 21388‐17‐0
Naproxen EP Impurity K 77301‐42‐9
Naproxen EP Impurity L/ Naproxen Related Compound L 3900‐45‐6
Naproxen EP Impurity M (Nerolin) 93‐04‐9
Naproxen EP Impurity N 5111‐65‐9
Naproxen Impurity O (Naproxen Isopropyl ester) 156967‐24‐7
Naproxen Related Compound A (Naproxen Carboxylic Impurity) 2471‐70‐7
Naproxen Impurity D 116883‐61‐5
rac‐5‐Chloro Naproxen 60424‐17‐1
rac‐5‐Bromo Naproxen 27655‐95‐4
Naproxen dehydro Impurity 27602‐79‐5
8.
Naproxen 2‐Propyl Ester 68641‐85‐0
n‐Butyrophenone 495‐40‐9
Product: NATEGLINIDE IMPURITIES
Nateglinide EP Impurity D (Aspartame EP Impurity C)
150‐30‐1
63‐91‐2
Nateglinide EP Impurity E (4‐Desisopropyl‐4‐Ethyl Nateglinide) 105746‐45‐0
Nateglinide EP Impurity F (D‐Phenylalanyl Nateglinide) 944746‐48‐9
Nateglinide EP Impurity G 187728‐85‐4
Nateglinide Impurity D 36877‐42‐6
Product: NEBIVOLOL IMPURITIES
Nebivolol Impurity A 118457‐16‐2
Nebivolol Impurity B 119365‐25‐2
Nebivolol Impurity C (2S*,2'R*) 793669‐26‐8
Nebivolol Impurity C (2S*,2'S*) 876514‐31‐7
Nebivolol Related Compound E (Monodesfluoro Nebivolol) 129101‐34‐4
(SR,RR) Nebivolol 213132‐06‐0
Product: NEOSTIGMINE IMPURITIES
Nor Neostigmine 16088‐19‐0
Neostigmine‐o‐isomer
Neostigmine‐p‐isomer
Product: NEPAFENAC IMPURITIES
Nepafenac Impurity A 2835‐77‐0
Nepafenac Impurity B 78281‐61‐5
Nepafenac Impurity D 51135‐38‐7
Nepafenac Impurity E 1246956‐18‐2
2‐(Methylthio)acetamide 22551‐24‐2
2‐Amino‐3‐benzoyl‐5‐chlorobenzeneacetamide 78281‐71‐7
2‐Amino‐5‐chlorobenzophenone 719‐59‐5
Product: NEVIRAPINE IMPURITIES
Nevirapine EP Impurity A/ Nevirapine Related Compound A 133627‐17‐5
9.
Nevirapine EP Impurity B/ Nevirapine Related Compound B 287980‐84‐1
Product: NICARDIPINE IMPURITIES
Nicardipine Related Compound A (Nicardipine Carboxylic Acid Impurity) 74936‐72‐4
Nicardipine Related Compound B (Nicardipine Pyridine Analog/ Dehydro Nicardipine)
59875‐58‐0
1216817‐27‐4
Nicardipine Related Compound C (Nicardipine Dimethyl Ester Analog/ m‐Nifedipine/ Nitrendipine EP Impurity B) 21881‐77‐6
Nicardipine Pyridine Monoacid Impurity 64603‐72‐1
2,6‐dimethyl‐4‐(3‐nitrophenyl)‐1,4‐dihydropyridine
Nicardipine Dimethyl Ester Analog 206976‐29‐6
3,5‐Pyridinedicarboxylic Acid 499‐81‐0
Nicardipine Bis Analog 71791‐90‐7
Product: NICORANDIL IMPURITIES
Nicorandil EP Impurity B 6265‐73‐2
Nicorandil EP Impurity D 40055‐37‐6
Product: NICOTINAMIDE IMPURITIES
Nicotinamide EP Impurity D (Isonicotinamide) 1453‐82‐3
Nicotinamide 3,5‐Dinitropyridine Impurity 940‐06‐7
Product: NICOTINE IMPURITIES
Nicotine EP Impurity B/ Nicotine Related Compound B (Nicotyrine) 487‐19‐4
Nicotine EP Impurity C/ Nicotine Related Compound C (Cotinine) 486‐56‐6
Nicotine EP Impurity D/ Nicotine Related Compound D (Myosmine) 532‐12‐7
Nicotine‐N‐Oxide/ 3‐(1‐methyl‐1‐oxidopyrrolidin‐1‐ium‐2‐yl)pyridine 63551‐14‐4
3‐[(1S,2S)‐1‐Methyl‐1‐oxido‐2‐pyrrolidinyl] 51095‐86‐4
Product: NICOTINIC ACID IMPURITIES
Nicotinic Acid EP Impurity E (Isonicotinic Acid) 55‐22‐1
Product: NIFEDIPINE IMPURITIES
Nifedipine EP Impurity A (Nifedipine nitrophenylpyridine analogue) 67035‐22‐7
Nifedipine EP Impurity B (Nifedipine nitrosophenylpyridine analog) 50428‐14‐3
Nifedipine EP Impurity C 39562‐27‐1
Nifedipine EP Impurity D 14205‐39‐1
10.
Nifedipine Monoamide/ Nifedipine Amide Impurity 114709‐68‐1
Product: NIFURATEL IMPURITIES
Nifuratel Impurity B 736‐53‐8
Product: NIFUROXAZIDE IMPURITIES
Nifuroxazide EP Impurity B (Methylparaben) 99‐76‐3
Nifuroxazide EP Impurity C 92‐55‐7
5‐nitro‐2‐furaldehyde 698‐63‐5
Product: NIFURSOL IMPURITIES
5‐nitro‐2‐furaldehyde 698‐63‐5
Product: NIMESULIDE IMPURITIES
Nimesulide EP Impurity A 51765‐56‐1
Nimesulide EP Impurity B 51765‐51‐6
Nimesulide EP Impurity C 2688‐84‐8
Nimesulide EP Impurity D 5422‐92‐4
Nimesulide EP Impurity E 905858‐63‐1
Nimesulide EP Impurity F 51765‐72‐1
Nimesulide EP Impurity G 70995‐08‐3
2‐Nitrodiphenyl Sulfide 4171‐83‐9
Product: NIMODIPINE IMPURITIES
Nimodipine EP Impurity B 21881‐78‐7
Nimodipine EP Impurity C/ Nimodipine Related Compound B (Cilnidipine Impurity 1) 70172‐96‐2
Product: NITRENDIPINE IMPURITIES
Nitrendipine EP Impurity B (Nicardipine Related Compound C/ Nicardipine Dimethyl Ester Analog/ m‐Nifedipine/
Lercanidipine Dimethyl Ester Impurity) 21881‐77‐6
Nitrendipine Dipropyl Ester 77888‐05‐2
Product: NIZATIDINE IMPURITIES
Nizatidine EP Impurity J 82586‐70‐7
Nizatidine EP Impurity K (Ranitidine EP Impurity G) 112233‐23‐5
Product: NORADRENALINE IMPURITIES/ NOREPINEPHRINE IMPURITIES
11.
Norepinephrine EP Impurity B 5090‐29‐9
Noradrenaline EP Impurity E 99‐40‐1
Norepinephrine EP Impurity F 20455‐68‐9
Norepinephrine EP Impurity G 13062‐58‐3
Noradrenaline Impurity C (Dopamine/ Dobutamine EP Impurity A)
51‐61‐6
62‐31‐7
Noradrenaline Impurity F (N,N‐Dibenzylamine) 103‐49‐1
Adrenaline/Epinephrine 51‐43‐4
Product: NORFLOXACIN IMPURITIES
Norfloxacin EP Impurity A/ Norfloxacin Related Compound A 68077‐26‐9
Norfloxacin EP Impurity B (Norfloxacin Desethylene Impurity/ Norfloxacin Ethylenediamine Analog) 75001‐77‐3
Norfloxacin EP Impurity C (Norfloxacin Dipiperazine Impurity) 177554‐64‐2
Norfloxacin EP Impurity D (Norfloxacin Descarboxy Impurity) 75001‐82‐0
Norfloxacin EP Impurity E/ Norfloxacin Related Compound E (Norfloxacin HCl 7‐Chloro Analog) 75001‐78‐4
Norfloxacin EP Impurity F (Norfloxacin 6‐Chloro Analog)
67681‐86‐1
67681‐84‐9
Norfloxacin EP Impurity G (Norfloxacin N‐Formyl Impurity) 70459‐04‐0
Norfloxacin EP Impurity H/ Norfloxacin Related Compound H (Norfloxacin N‐Ethoxycarbonyl Impurity) 105440‐01‐5
Norfloxacin EP Impurity K/ Norfloxacin Related Compound K 70459‐07‐3
Product: NORTRIPTYLINE IMPURITIES
Nortriptyline EP Impurity A (Amitriptyline EP Impurity A/ Amitriptyline Related Compound A/ Cyproheptadine EP
Impurity B/ Dibenzosuberone) 1210‐35‐1
Nortriptyline EP Impurity B (Cyclobenzaprine Related Compound B/ Desmethyl Cyclobenzaprine)
303‐50‐4
438‐59‐5
Nortriptyline EP Impurity D (Amitriptyline EP Impurity D/ Amitriptyline Related Compound B/ Amitriptynol) 1159‐03‐1
Nortriptyline EP Impurity I (Amitriptyline EP Impurity G/ Dibenzosuberol) 1210‐34‐0
12.
Nortriptyline EP Impurity J (Amitriptyline N‐Oxide) 4317‐14‐0
Product: OFLOXACIN IMPURITIES
Ofloxacin EP Impurity A (Ofloxacin Difluoro Carboxylic Acid) 82419‐35‐0
Ofloxacin EP Impurity C (Ofloxacin Desfluoro Impurity) 95848‐94‐5
Ofloxacin EP Impurity D Ethyl Ester 2172959‐66‐7
Ofloxacin EP Impurity E (Desmethyl Ofloxacin) 82419‐52‐1
Ofloxacin EP Impurity F (Ofloxacin N‐Oxide) 104721‐52‐0
Ofloxacin R‐Isomer 100986‐86‐5
Ofloxacin Desethylene Impurity 1797983‐25‐5
Ofloxacin Desfluoro Acid 56346‐18‐0
Product: OLANZAPINE IMPURITIES
Olanzapine EP Impurity A/ Olanzapine Related Compound A 138564‐59‐7
Olanzapine EP Impurity B/ Olanzapine Related Compound B 221176‐49‐4
Olanzapine EP Impurity C (Chloromethyl Olanzapinium chloride)
719300‐59‐1
735264‐27‐4
Olanzapine EP Impurity D/ Olanzepine Related Compound C (Olanzapine N‐Oxide) 174794‐02‐6
Olanzapine Impurity‐A/ Olanzapine N‐Desmethyl 161696‐76‐0
Olanzapine Impurity 1/ Olanzapine Amino 873895‐41‐1
Olanzapine N‐Formyl Impurity 639460‐79‐0
Olanazpine LIP 1 Acetyl 935272‐10‐9
Olanzapine Thiohydroxymethylidene 1320360‐86‐8
Olanzapine Lactone Impurity 1017241‐34‐7
Olanzapine Thiolactam 1017241‐36‐9
Olanzapine Amine Impurity 138564‐60‐0
Olanzapine Ring‐opening Impurity 138564‐61‐1
N‐Desmethyl N‐Ethyl Olanzapine 1355034‐54‐6
Olanzapine Dimer Impurity
4‐Amino‐2‐methyl‐10H‐thieno[2,3‐b][1,5]‐benzodiazapine
612503‐08‐9
138564‐60‐0
4,4'‐(1,4‐Piperazinediyl)bis[2‐methyl‐10H‐thieno[2,3‐b][1,5]benzodiazepine] 1070876‐09‐3
14.
Olmesartan Medoxomil Methyl Ether/ Olmesartan Medoxomil O‐Methyl Analog 896419‐17‐3
Olmesartan Methyl Ether/ O‐Methyl Olmesartan Acid 1039762‐40‐7
Olmesartan Medoxomil Ethyl Analog/ Ethyl Olmesartan Medoxomil 1378863‐74‐1
Olmesartan Ethyl Ester N2‐Trityl Analog 172875‐59‐1
Olmesartan Dimer Ester 1040250‐19‐8
Product: OLOPATADINE IMPURITIES
Olopatadine Related Compound B (Olopatadine N‐Oxide)
203188‐31‐2
173174‐07‐7
Olopatadine Related Compound C 55453‐87‐7
Olopatadine (E)‐Isomer
949141‐22‐4
113806‐06‐7
Olapatidin Acetaldehyde/ Olopatadine Carbaldehyde 1376615‐97‐2
Olopatadine Isopropyl Ester 1206456‐44‐1
Olopatadine Ethyl Ester 1253107‐27‐5
Olopatadine Hydroxy Derivative 949141‐21‐3
Product: OMEPRAZOLE IMPURITIES
Omeprazole EP Impurity A/ Omeprazole Related Compound B (Esomeprazole EP Impurity A) 37052‐78‐1
Omeprazole EP Impurity B (Esomeprazole EP Impurity B/ Desmethoxy Omeprazole) 110374‐16‐8
Omeprazole EP Impurity C (Omeprazole Sulfide/ Ufiprazole/ Esomeprazole EP Impurity C) 73590‐85‐9
Omeprazole EP Impurity D (Omeprazole Sulfone/ Esomeprazole EP Impurity D/ Esomeprazole Related Compound A) 88546‐55‐8
Omeprazole EP Impurity E/ Omeprazole Related Compound E (Omeprazole N‐Oxide/ Esomeprazole EP Impurity E) 176219‐04‐8
Omeprazole EP Impurity F/ Omeprazole Related Compound F 125656‐82‐8
Omeprazole EP Impurity G/ Omeprazole Related Compound G 125656‐83‐9
Omeprazole EP Impurity H (Esomeprazole Impurity H) 863029‐89‐4
15.
Omeprazole EP Impurity I/ Omeprazole Related Compound I (Omeprazole Sulfone N‐Oxide/ Esomeprazole Impurity
Sulfone N‐Oxide) 158812‐85‐2
Omeprazole EP Impurity XI
84006‐10‐0
86604‐75‐3
Omeprazole 4‐Desmethyl Impurity 301669‐82‐9
5‐O‐Desmethyl omeprazole 1151602‐49‐2
Omeprazole R‐Isomer (Esomeprazole EP Impurity F) 161796‐77‐6
Omeprazole N‐Methyl 5‐Methoxy Analog 89352‐76‐1
Omeprazole Pyridone Acid 1227380‐90‐6
4‐Hydroxy Omeprazole Sulfide/ Omeprazole Pyridone 103876‐98‐8
4,5’‐Di(desmethyl) Omeprazole Sulfide 176219‐12‐8
Omeprazole S‐Isomer 119141‐88‐7
Product: ONDANSETRON IMPURITIES
Ondansetron EP Impurity A/ Ondansetron Related Compound A
153139‐56‐1
119812‐29‐2
Ondansetron EP Impurity B/ Ondansetron Related Compound B (Ondansetron Dimer) 1076198‐52‐1
Ondansetron EP Impurity C/ Ondansetron Related Compound C 27387‐31‐1
Ondansetron EP Impurity D/ Ondansetron Related Compound D 99614‐64‐9
Ondansetron EP Impurity E (Enalapril EP Impurity I/ Imidazole/ Clotrimazole EP Impurity D/ Bifonazole EP Impurity C) 288‐32‐4
Ondansetron EP Impurity F 693‐98‐1
Ondansetron EP Impurity G (C‐Desmethyl Ondansetron) 99614‐03‐6
Ondansetron EP Impurity H (N‐Desmethyl Ondansetron) 9614‐14‐9
Product: ORLISTAT IMPURITIES
Orlistat Related Compound C (Triphenylphosphine Oxide) 791‐28‐6
Orlistat Related Compound D 130793‐27‐0
Orlistat Open Ring Epimer impurity (Orlistat Open Ring (2S,3R,5S)‐Isomer) 130793‐28‐1
Orlistat Open Ring Acid impurity ( Orlistat Open Ring (2S,3S,5S)‐Isomer) 130676‐66‐3
Orlistat Dihydropyranone Impurity 130676‐64‐1
16.
Product: ORNIDAZOLE IMPURITIES
Ornidazole 4‐Nitro Isomer 14419‐11‐5
Ornidazole Impurity 1 (Tinidazole EP Impurity A/ Tinidazole Related Compound A/ Metronidazole EP impurity A) 696‐23‐1
Product: ORPHENADRINE IMPURITIES
Orphenadrine EP Impurity D (Diphenhydramine) 147‐24‐0
Product: OSELTAMAVIR IMPURITIES
Oseltamivir EP Impurity A 1364932‐19‐3
Oseltamivir EP Impurity C (Oseltamivir Acid) 187227‐45‐8
Oseltamivir EP Impurity D 1346604‐18‐9
Oseltamivir EP Impurity E (Oseltamivir Acid Methyl Ester) 208720‐71‐2
Oseltamivir EP Impurity G (4‐N‐Desacetyl‐5‐N‐Acetyl Oseltamivir) 956267‐10‐0
Oseltamivir Related Compound A
Oseltamavir Ethyl ester
Product: OSPEMIFENE IMPURITIES
Vinyl Ospemifene
Ospemifene Impurity 1 (Fispemifene) 341524‐89‐8
Ospemifene Impurity 2 89778‐42‐7
Reduced Ospemifene impurity
Ospemifene E‐Isomer 238089‐02‐6
4‐Deschloro‐4‐bromo Ospemifene
Product: OXAPROZIN IMPURITIES
4‐Oxo‐4‐[(2‐oxo‐1,2‐diphenylethyl)amino]‐butanoic Acid 55217‐13‐5
Product: OXAZOLIDINE IMPURITIES
Oxazolidine‐2‐thione 5840‐81‐3
1,9‐Bis(4‐fluorophenyl)nonane‐1,5,9‐trione 914777‐33‐6
Product: OXCARBAZEPINE IMPURITIES
Oxcarbazepine EP Impurity B (10‐Methoxycarbamazepine) 28721‐09‐7
Oxcarbazepine EP Impurity C/ Oxcarbazepine Related Compound E 21737‐58‐6
Oxcarbazepine EP Impurity D 19579‐83‐0
17.
Oxcarbazepine EP Impurity E (Carbamazepine EP Impurity D/ Carbamazepine Related Compound B/ Iminostilbene) 256‐96‐2
Oxcarbazepine EP Impurity F 28721‐08‐6
Oxcarbazepine EP Impurity G 15882‐79‐8
Oxcarbazepine EP Impurity H (10‐Methoxy Iminostilbene) 4698‐11‐7
Oxcarbazepine EP Impurity I (11‐Keto Oxcarbazepine) 537693‐29‐1
Oxcarbazepine EP Impurity K/ Oxcarbazepine Related Compound A (N‐Formyl Oxcarbazepine) 1346601‐76‐0
Oxcarbazepine EP Impurity L/ Oxcarbazepine Related Compound B
Carbamazepine 298‐46‐4
Licarbazepine 29331‐92‐8
9‐methylacridine (Carbamazepine EP Impurity B/ Carbamazepine Related Compound D) 611‐64‐3
Acridin‐9(10H)‐one 578‐95‐0
Product: OXIFLOXACIN IMPURITIES
Oxifloxacin EP Impurity F (Levofloxacin EP Impurity C/ Levofloxacin N‐oxide)
117678‐38‐3
117678‐37‐2
Product: OXYBUTYNIN IMPURITIES
Oxybutynin EP Impurity B (Diphenyl Analogue of Oxybutynin) 14943‐53‐4
Oxybutynin EP Impurity C 1199574‐70‐3
Oxybutynin EP Impurity D/ Oxybutynin Related Compund A (Phenylcyclohexylglycolic acid) 4335‐77‐7
Oxybutynin EP Impurity E 1215677‐72‐7
Oxybutynin Related Compound B (Cyclohexyl mandelic acid methyl ester) 10399‐13‐0
Quinuclidin‐3‐yl 2‐hydroxy‐2,2‐diphenylacetate 6581‐06‐2
Methyl 2‐hydroxy‐2,2‐diphenylacetate 76‐89‐1
Ethyl 2‐Cyclohexyl‐2‐hydroxyphenylacetate 31197‐69‐0
Oxybutynin N‐Oxide 80976‐68‐7
Product: OXYMETAZOLINE IMPURITIES
Oxymetazoline EP Impurity A/ Oxymetazoline Related Compound A
1391194‐44‐7
1391053‐50‐1
Oxymetazoline EP Impurity B (Xylometazoline) 1218‐35‐5
Oxymetazoline EP Impurity C 55699‐13‐3
18.
Oxymetazoline EP Impurity D 55699‐12‐2
Oxymetazoline EP Impurity E 55699‐10‐0
6‐tert‐Butyl‐2,4‐dimethylphenol 1879‐09‐0
4‐tert butyl‐2,6‐dimethyl‐3‐hydroxy benzyl chloride 23500‐79‐0
Product: PACLITAXEL IMPURITIES
Paclitaxel EP Impurity E (7‐epi‐Paclitaxel) 105454‐04‐4
Paclitaxel EP Impurity G (10‐Desacetyl Paclitaxel) 78432‐77‐6
Paclitaxel EP Impurity H (7‐Epi 10‐Desacetyl Paclitaxel) 78454‐17‐8
10‐Deacetyl Baccatin III 32981‐86‐5
Product: PALBOCICLIB IMPURITIES
6‐Bromo‐2‐chloro‐8‐cyclopentyl‐5‐methylpyrido‐[2,3‐d]pyrimidin‐7(8H)‐one 1016636‐76‐2
1‐Boc‐4‐(6‐aminopyridin‐3‐yl)piperazine 571188‐59‐5
Product: PALIPERIDONE IMPURITIES
Paliperidone Related Compound A (Paliperidone Ethyl Impurity)
849903‐79‐3
849727‐64‐6
Paliperidone Related Compund B (Paliperidone Amine Impurity/ Risperidone EP Impurity M) 84163‐13‐3
Paliperidone Related Compound C (Paliperidone Chloroethyl Impurity) 130049‐82‐0
Paliperidone Related Compound D (Paliperidone N‐Oxide) 761460‐08‐6
Paliperidone N‐1 Intermediate 147687‐17‐0
Paliperidone Tetradehydro Impurity (6,7,8,9‐Dehydro Paliperidone/ 6,7,8,9‐Dehydro 9‐Hydroxy Risperidone) 170359‐61‐2
Paliperidone 9‐Keto Impurity (9‐Keto Risperidone/ 9‐Oxo Risperidone) 1189516‐65‐1
Risperidone 106266‐06‐2
Paliperidone 5‐Fluoro Isomer 1346598‐34‐2
Paliperidone Z‐Oxime 1388021‐47‐3
2‐Desmethyl Paliperidone 1268058‐08‐7
Paliperidone (E)‐Oxime 1388021‐46‐2
(4‐fluoro‐2‐hydroxyphenyl)‐4‐piperidinyl‐, hydrochloride 81043‐50‐7
Paliperidone Desfluoro Impurity 1380413‐60‐4
Paliperidone R‐Isomer 130049‐85‐3
19.
Paliperidone S‐Isomer 147663‐01‐2
Paliperidone Tetradehydro Chloroethyl Impurity
260273‐82‐3
849727‐62‐4
Product: PALONOSETRON IMPURITIES
Palonosetron Related Compound A (Palonosetron N‐Oxide) 813425‐83‐1
Palonosetron Related Compound B (Palonosetron‐3‐ene N‐Oxide) 1021456‐82‐5
Palonosetron Related Compound C (Palonosetron (S,R)‐Isomer)
149654‐00‐2
135729‐76‐9
Palonosetron Related Compound D (Palonosetron (R,S)‐Isomer) 135755‐51‐0
Palonosetron Related Compound E (Palonosetron‐3‐ene HCl) 135729‐55‐4
(S)‐N‐(1‐Azabicyclo[2.2.2]oct‐3‐yl)‐5,6,7,8‐tetrahydro‐1‐naphthalenecarboxamide 135729‐78‐1
Dehydropalonosetron
Palonosetron Enantiomer ( Palonosetron (R,R)‐Isomer) 135729‐75‐8
Methyl 5,6,7,8‐tetrahydronaphthalene‐1‐carboxylate 66193‐59‐7
Product: PANTOPRAZOLE IMPURITIES
Pantoprazole EP Impurity A/ Pantoprazole Related Compound A (Pantoprazole Sulfone) 127780‐16‐9
Pantoprazole EP Impurity B/ Pantoprazole Related Compound B (Pantoprazole Sulfide) 102625‐64‐9
Pantoprazole EP Impurity C/ Pantoprazole Related Compound C (Pantoprazole Thiol Impurity) 97963‐62‐7
Pantoprazole EP Impurity D/ Pantoprazole Related Compound D (N1‐Methyl Pantoprazole) 624742‐53‐6
Pantoprazole EP Impurity F/ Pantoprazole Related Compound F (N‐Methyl Pantoprazole 6‐(Difluoromethoxy) Analog) 721924‐06‐7
Pantoprazole Related Compound E (Pantoprazole Dimer) 2115779‐15‐0
Pantoprazole Chloromethyl Impurity 72830‐09‐2
Pantoprazole N‐Oxide
953787‐60‐5
1279822‐90‐0
Pantoprazole Sulfone N‐Oxide 953787‐55‐8
20.
Product: PARABEN IMPURITIES
Butylparaben Impurity E 4247‐02‐3
Product: PARACETAMOL IMPURITIES/ ACETAMINOPHEN IMPURITIES
Paracetamol EP Impurity A 614‐80‐2
Paracetamol EP Impurity B 1693‐37‐4
Paracetamol EP Impurity D 103‐84‐4
Paracetamol EP Impurity E 99‐93‐4
Paracetamol EP Impurity F 100‐02‐7
Paracetamol EP Impurity G 198712‐64‐0
Paracetamol EP Impurity H 2623‐33‐8
Paracetamol EP Impurity I 118‐93‐4
Paracetamol EP Impurity J 539‐03‐7
Paracetamol EP Impurity K
123‐30‐8
51‐78‐5
Product: PAROXETINE IMPURITIES
Paroxetine EP Impurity A/ Paroxetine Related Compound B (Desfluoro Paroxetine)
1394842‐91‐1
324024‐00‐2
1322626‐23‐2
Paroxetine EP impurity E/ Paroxetine Related Compound D (cis‐Paroxetine)
105813‐05‐6
1396174‐70‐1
Paroxetine EP Impurity F (N‐Benzyl Desfluoro Paroxetine) 105813‐39‐6
Paroxetine Anhydrous EP Impurity B 533‐31‐3
Paroxetine Anhydrous EP Impurity C (N‐benzylparoxetine) 105813‐14‐7
Paroxetine Hemihydrate EP Impurity C (4‐Ethoxy Paroxetine)
606968‐04‐1
1395408‐54‐4
1346597‐97‐4
Paroxetine HCl Hemihydrate EP Impurity G/ Paroxetine HCl Related Compound E
69675‐10‐1
1012886‐75‐7
Paroxetine Related Compound F 110429‐36‐2
N‐Benzyl Paroxetine 105813‐13‐6
22.
Product: PENICILLAMINE IMPURITIES
3,3’‐Trithiobis‐D‐valine 22801‐32‐7
Product: PENTOXIFYLLINE IMPURITIES
Pentoxifylline EP Impurity A (Theobromine) 83‐67‐0
Pentoxifylline EP Impurity B (Theophylline EP Impurity B/ Linagliptin 3‐Methyl Xanthine Impurity) 1076‐22‐8
Pentoxifylline EP Impurity C (Diprophylline EP Impurity B/ Caffeine EP Impurity A/ Theophylline/ Dimenhydrinate EP
Impurity A) 58‐55‐9
Pentoxifylline EP Impurity F (Theophylline EP Impurity A/ caffeine) 58‐08‐2
Product: PERAZINE IMPURITIES
Perazine Sulfoxide 20627‐44‐5
Perazine Dimer
Product: PERINDOPRIL IMPURITIES
Perindopril EP Impurity A (Ramipril Bicyclic Acid) 80875‐98‐5
Perindopril EP Impurity B/ Perindopril Related Compound B (Perindoprilat/ Perindopril Diacid) 95153‐31‐4
Perindopril EP Impurity C (Perindoprilat Lactam A) 129970‐99‐6
Perindopril EP Impurity D/ Perindopril Related Compound D 130061‐28‐8
Perindopril EP Impurity E/ Perindopril Related Compound E (Perindoprilat Isopropyl Ester) 1356837‐89‐2
Perindopril EP Impurity F/ Perindopril Related Compound F (Perindopril Diketopiperazine) 129970‐98‐5
(1R)‐Perindopril t‐Butylamine Salt 145513‐33‐3
Perindopril Benzyl Ester 122454‐52‐8
Product: PERMETHRIN IMPURITIES
Permethrin EP Impurity A 3586‐14‐9
Permethrin EP Impurity B (Permethrinic Acid Methyl Ester) 61898‐95‐1
Permethrin EP Impurity C 13826‐35‐2
Permethrin EP Impurity D 39515‐51‐0
Permethrin EP Impurity E 53874‐66‐1
Permethrin EP Impurity G 85576‐82‐5
Product: PERPHENAZINE IMPURITIES
23.
Perphenazine EP Impurity A (Perphenazine Sulfoxide) 10078‐25‐8
Product: PHENIRAMINE IMPURITIES
4‐Benzylpyridine 2116‐65‐6
Pheniramine EP Impurity A 101‐82‐6
Product: PHENOXYBENZAMINE IMPURITIES
Phenoxybenzamine Hydroxide 101‐45‐1
Phenoxybenzamine N‐Oxide
Product: PHENYLEPHRINE IMPURITIES
Phenylephrine EP Impurity A (Etilefrine EP Impurity C/ rac Norphenylephrine)
536‐21‐0
4779‐94‐6
5596‐07‐6
Phenylephrine EP Impurity C / Phenylephrine Related Compound C (Phenylephrone)
52093‐42‐2
94240‐17‐2
Phenylephrine EP Impurity D 1159977‐09‐9
Phenylephrine EP Impurity E / Phenylephrine Related Compound E (Benzyl Phenylephrone)
56917‐44‐3
71786‐67‐9
Phenylephrine Related Compound D 1367567‐95‐0
N‐(2‐Succinyl) Phenylephrine Impurity 915278‐80‐7
Product: PHENYTOIN IMPURITIES
Phenytoin EP Impurity A (Diphenhydramine EP Impurity E/ Diphenylmethanone/ Benzophenone) 119‐61‐9
Product: PICOSULFATE IMPURITIES
Picosulfate EP Impurity B 603‐41‐8
Product: PIOGLITAZONE IMPURITIES
Pioglitazone EP Impurity A (Pioglitazone 5‐Hydroxy Metabolite) 625853‐74‐9
Pioglitazone EP Impurity B (Pioglitazone Didehydro Impurity)
627502‐58‐3
144809‐28‐9
136401‐69‐9
Pioglitazone EP Impurity C/ Pioglitazone Related Compound C (N‐Alkyl Pioglitazone) 952188‐00‐0
Pioglitazone EP Impurity D 868754‐41‐0
24.
Pioglitazone EP Impurity E (Pioglitazone Ethyl Ester Impurity) 868754‐42‐1
Pioglitazone EP Impurity F (Pioglitazone bis‐Ether Impurity) 1391052‐15‐5
Pioglitazone EP Impurity G 952187‐99‐4
Pioglitazone Bromo Impurity 669716‐58‐9
Pioglitazone Phenol Impurity (Pioglitazone M1 Metabolite) 74772‐78‐4
Pioglitazone N‐Oxide 145350‐09‐0
5‐[[4‐[2‐(5‐(1‐Hydroxyethyl)‐2‐pyridinyl)ethoxy]phenyl]methyl]‐2,4‐thiazolidinedione 146062‐44‐4
Product: PIPERACILLIN IMPURITIES
Piperacillin EP Impurity H (Flucloxacillin EP Impurity C/ Cloxacillin EP Impurity C/ Ampicillin EP Impurity A/ Amoxicillin
EP Impurity A/ Amoxicillin Related Compound A/ Sulbactam EP Impurity B/ 6‐Aminopenicillanic Acid) 551‐16‐6
Product: PIPERAQUINE IMPURITIES
Piperaquine Impurity A 837‐52‐5
Piperaquine Impurity H 31502‐87‐1
7‐Chloro‐4‐[4‐(3‐chloropropyl)‐1‐piperazinyl]‐quinoline 4038‐99‐7
Product: PIRACETAM IMPURITIES
Piracetam EP Impurity A (Povidone EP Impurity B/ pyrrolidin‐2‐one/Levetiracetam Impurity 3/2‐Oxo‐4‐butyrolactam) 616‐45‐5
Piracetam EP Impurity B 59776‐88‐4
Piracetam EP Impurity C 61516‐73‐2
Piracetam EP Impurity D 53934‐76‐2
Product: PIRFENIDONE IMPURITIES
Pirfenidone EP Impurity A 1603‐41‐4
Pirfenidone EP Impurity B 1003‐68‐5
Pirfenidone EP Impurity C (Phenol) 108‐95‐2
Pirfenidone EP Impurity D (Bromobenzene) 108‐86‐1
Pirfenidone 5‐Carboxylic Acid Impurity
77837‐08‐2
1189982‐99‐7
Methyl 1,6‐dihydro‐6‐oxo‐1‐phenylpyridine‐3‐carboxylate 77837‐09‐3
N‐(4‐Hydroxyphenyl)‐5‐methyl‐2‐1H‐pyridone 851518‐71‐3
25.
Product: PIROXICAM IMPURITIES
Piroxicam EP Impurity A (Tenoxicam EP Impurity A/ Mepyramine EP Impurity C/ 2‐Aminopyridine) 504‐29‐0
Piroxicam EP Impurity B (N‐Desmethyl Piroxicam) 65897‐46‐3
Piroxicam EP Impurity C 24683‐25‐8
Piroxicam EP Impurity D 6639‐62‐9
Piroxicam EP Impurity E 24683‐20‐3
Piroxicam EP Impurity F 76508‐37‐7
Piroxicam EP Impurity G 35511‐14‐9
Piroxicam EP Impurity H 24683‐21‐4
Piroxicam EP Impurity I 76508‐35‐5
Piroxicam EP Impurity J (Meloxicam EP Impurity E) 35511‐15‐0
Piroxicam EP Impurity K (Meloxicam EP Impurity A/ Meloxicam Related Compund A)
113913‐36‐3
24683‐26‐9
Piroxicam EP Impurity L (Meloxicam EP Impurity F/ Meloxicam Related Compund C) 118854‐48‐1
Product: PITAVASTATIN IMPURITIES
Pitavastatin Desfluoro Acetonide t‐Butyl Ester
Defluoro Pitavastatin Calcium Salt
847849‐67‐6
1258947‐30‐6
Pitavastatin (3S,5R)‐Isomer Calcium Salt (Pitavastatin Enantiomer)
254452‐86‐3
254452‐88‐5
Pitavastatin Dihydrobenzophenanthridine Impurity 1187966‐91‐1
Pitavastatin Lactone 141750‐63‐2
Pitavastatin Acetonide t‐Butyl Ester 147489‐06‐3
Pitavastatin Methyl Ester 849811‐78‐5
Pitavastatin t‐Butyl Ester 586966‐54‐3
Pitavastatin N‐Oxide
2276678‐27‐2
1611499‐16‐1
2‐Amino‐2'‐fluorobenzophenone 1581‐13‐1
26.
Product: PLERIXAFOR IMPURITIES
Plerixafor 1,4,8,11‐Tetraazacyclotetradecane/ 1,4,8,11‐Tetraazacyclotetradecane 295‐37‐4
4‐(1,4,8,11‐Tetraazacyclotetradec‐1‐ylmethyl)‐Benzenemethanol 176252‐20‐3
1‐(4‐Methylbenzyl)‐1,4,8,11‐tetraazacyclotetradecane 351472‐73‐6
1,8‐Bis(4‐((1,4,8,11‐tetraazacyclotetradecan‐1‐yl)methyl)benzyl)‐1,4,8,11‐tetraazacyclotetradecane 414858‐02‐9
Product: POMALIDOMIDE IMPURITIES
N‐Hydroxy Pomalidomide/ Hydroxyl‐amine impurity 497147‐11‐2
Pomalidomide Uncyclized Impurity 1001852‐10‐3
Pomalidomide Hydrolyzed 918314‐45‐1
(R)‐2‐(2,6‐Dioxopiperidin‐3‐yl)‐4‐nitroisoindoline‐1,3‐dione 19171‐18‐7
Product: POSACONAZOLE IMPURITIES
Posaconazole Impurity B/ Posaconazole Desethylene Diformyl Impurity 357189‐95‐8
Posaconazole 3‐Oxo Impurity 357189‐94‐7
Posaconazole Diastereoisomer Related Compound 1 159811‐30‐0
Posaconazole Dioxido Impurity 1902957‐95‐2
1‐((2S,3S)‐2‐(Benzyloxy)pentan‐3‐yl)‐N‐(4‐(4‐(4‐hydroxyphenyl)piperazin‐1‐yl)phenyl)hydrazinecarboxamide 345217‐02‐9
Posaconazole Tosyl Impurity 149809‐43‐8
Posaconazole 1‐Oxido Impurity 1902954‐03‐3
Posaconazole 4‐Oxido Impurity 1902954‐05‐5
4‐[4‐(4‐Aminophenyl)‐1‐piperazinyl]phendiamineol 74853‐08‐0
Product: POVIDONE IMPURITIES
Povidone EP Impurity B (Piracetam EP Impurity A/ pyrrolidin‐2‐one/Levetiracetam Impurity 3/2‐Oxo‐4‐butyrolactam) 616‐45‐5
Product: PRAMIPEXOLE IMPURITIES
Pramipexole EP Impurity A/ Pramipexole Related Compound A ((S)‐N‐Despropyl Pramipexole)
106092‐09‐5
104617‐49‐4
Pramipexole EP Impurity B (2‐N‐Propyl Pramipexole) 1246815‐83‐7
Pramipexole EP Impurity D/ Pramipexole Related Compound D (Pramipexole R‐Isomer/ Dexpramipexole)
104632‐28‐2
104632‐27‐1
Pramipexole EP Impurity E/ Pramipexole Related Compound B ((S)‐Pramipexole Amide) 106006‐84‐2
28.
Praziquantel EP Impurity A/ Praziquantel Related Compound A (Praziquantel N‐Benzoyl Impurity) 54761‐87‐4
Praziquantel EP Impurity B/ Praziquantel Related Compound B 125273‐86‐1
Praziquantel EP Impurity C/ Praziquantel Related Compound C 125273‐88‐3
Product: PRAZOSIN IMPURITIES
Prazosin EP Impurity A (Alfuzosin EP Impurity B/ Terazosin EP Impurity A/ Doxazosin EP Impurity F/ Doxazosin Related
Compund C) 23680‐84‐4
Prazosin EP Impurity B (Terazosin EP Impurity M) 31350‐27‐3
Prazosin EP Impurity C (Doxazosin EP Impurity G/ Terazosin EP Impurity C/ Terazosin Related Compound A)
60547‐97‐9
60548‐08‐5
Prazosin EP Impurity D/ Prazosin Related Compound D (Terazosin EP Impurity L)
60548‐09‐6
40172‐95‐0
Prazosin EP Impurity E (Doxazosin EP Impurity H/ Terazosin EP Impurity E/ Terazosin Related Compound C)
102839‐00‐9
1486464‐41‐8
104965‐50‐6
Product: PREDNISOLONE IMPURITIES
Prednisolone EP Impurity A/ Hydrocortisone Acetate EP Impurity A (Hydrocortisone/Cortisol) 50‐23‐7
Prednisolone EP Impurity B (Prednisone) 53‐03‐2
Prednisolone EP Impurity C (Hydrocortisone Acetate EP Impurity C/ Methylprednisolone Acetate EP Impurity E) 52‐21‐1
Prednisolone Acetate EP Impurity C (Prednisolone 11,21‐Diacetate Impurity) 98523‐85‐4
Sodium 3‐Sulfobenzoate 17625‐03‐5
Product: PREGABALIN IMPURITIES
Pregabalin EP Impurity B/ Pregabalin Related Compound A (Pregabalin (R)‐Isomer) 148553‐51‐9
Pregabalin EP Impurity C 90‐64‐2
Pregabalin EP Impurity D 4118‐51‐8
Pregabalin Racemate 128013‐69‐4
Pregabalin Methyl Ester
714230‐22‐5
1955557‐35‐3
Pregabalin N‐Methyl Impurity 1155843‐61‐0
30.
Promethazine EP Impurity C (N‐Desmethyl Promethazine) 60113‐77‐1
Promethazine EP Impurity D (Promethazine Sulfoxide) 7640‐51‐9
2‐Dimethylaminoisopropyl chloride 4584‐49‐0
10H‐phenothiazine‐2‐carboxylic Acid Amide 1778‐82‐1
2‐Bromo‐10H‐phenothiazine 66820‐95‐9
Product: PROPAFENONE IMPURITIES
Propafenone EP Impurity A 3516‐95‐8
Propafenone EP Impurity B/ Propafenone Related Compound B (Propafenone Didehydro Impurity) 88308‐22‐9
Propafenone EP Impurity C 22525‐95‐7
Propafenone EP Impurity D (Despropylamino Hydroxy Propafenone) 91401‐73‐9
Propafenone EP Impurity E (Despropylamino Chloro Propafenone) 165279‐79‐8
Propafenone EP Impurity F 1329643‐40‐4
Propafenone EP Impurity G 1346603‐80‐2
Propafenone EP Impurity H (Flavanone)
487‐26‐3
27439‐12‐9
Propafenone N‐Despropyl
86383‐21‐3
1188263‐52‐6
93885‐20‐2
5‐Hydroxy Propafenone Hydrochloride 86384‐10‐3
Product: PROPARACAINE IMPURITIES
4‐Chloro‐3‐nitrobenzoic acid 96‐99‐1
Product: PROPOFOL IMPURITIES
Propofol EP Impurity E/ Propofol Related Compund A 2416‐95‐7
Propofol EP Impurity G/ Propofol Related Compund C 141214‐18‐8
Propofol EP Impurity K 14366‐59‐7
Propofol EP Impurity O 74663‐48‐2
Product: PROPRANOLOL IMPURITIES
Propranolol EP Impurity B 83314‐78‐7
Propranolol EP Impurity C 17216‐10‐3
31.
Naphthalen‐1‐ol (Duloxetine EP Impurity D/ α‐Napthol) 90‐15‐3
Epichlorohydrin 106‐89‐8
Propranolol Epoxide impurity 2461‐42‐9
1‐chloro‐3‐(1‐naphthyloxy)propan‐2‐ol 20133‐93‐1
Propranolol Glycol 36112‐95‐5
Product: PROPYLPARABEN IMPURITIES
Methylparaben (Nifuroxazide EP Impurity B) 99‐76‐3
Ethyl Paraben 120‐47‐8
Product: PYRANTEL IMPURITIES
Pyrantel Impurity C (2‐Thenaldehyde) 98‐03‐3
Product: PYRAZINAMIDE IMPURITIES
Pyrazinamide EP Impurity A 98‐97‐5
Product: PYRIDOSTIGMINE IMPURITIES
Pyridostigmine EP Impurity A/ Pyridostigmine Related Compound A 51581‐32‐9
Pyridostigmine Related Compound B 31034‐86‐3
Product: PYRIDOXINE IMPURITIES
Pyridoxine EP Impurity B
65‐23‐6
58‐56‐0
Pyridoxine Impurity A (Pyridoxine Cyclic Ether)
5196‐20‐3
1006‐21‐9
Pyridoxine Impurity B (4‐Deoxy Pyridoxine)
61‐67‐6
148‐51‐6
Product: QUETIAPINE IMPURITIES
Quetiapine EP Impurity A 844639‐07‐2
Quetiapine EP Impurity B/ Quetiapine Related Compound B (Quetiapine DBTP Metabolite) 111974‐74‐4
Quetiapine EP Impurity C 1798840‐31‐9
Quetiapine EP Impurity D/Quetiapine Bis(dibenzothiazepinyl) piperazine Impurity (Quetiapine Dimer Impurity) 945668‐94‐0
Quetiapine EP Impurity E (Quetiapine bis‐Ether) 1371638‐05‐9
Quetiapine EP Impurity F 848814‐27‐7
Quetiapine EP Impurity G/ Quetiapine Related Compound G (Quetiapine DBTO Metabolite/ Quetiapine Lactam) 3159‐07‐7
33.
Product: QUINAPRIL IMPURITIES
Quinapril EP Impurity C/ Quinapril Related Compound B (Quinaprilat/ Quinapril Diacid) 82768‐85‐2
Quinapril EP Impurity D/ Quinapril Related Compound A (Quinapril Diketopiperazine) 103733‐49‐9
Quinapril ethyl ester 103733‐35‐3
O‐Desethyl‐O‐isopropyl Quinapril 955034‐25‐0
Product: QUININE IMPURITIES
Quinine EP Impurity B (Cinchonidine)
485‐71‐2
24302‐67‐8
10,11‐Didehydrocinchonidine 157253‐80‐0
Dihydroquinine 522‐66‐7
Product: RABEPRAZOLE IMPURITIES
Rabeprazole EP Impurity A/ Rabeprazole Related Compound D (Rabeprazole Sulfone) 117976‐47‐3
Rabeprazole EP Impurity B/ Rabeprazole Related Compound E (Rabeprazole Sulfide) 117977‐21‐6
Rabeprazole EP Impurity C/ Rabeprazole Related Compound A 1163685‐30‐0
Rabeprazole EP Impurity D/ Rabeprazole Related Compound B (Rabeprazole N‐Oxide) 924663‐38‐7
Rabeprazole EP Impurity E (Rabeprazole 4‐Methoxy Analog) 102804‐77‐3
Rabeprazole EP Impurity F/Rabeprazole Related Compound C (Lansoprazole EP Impurity E) 583‐39‐1
Rabeprazole EP Impurity G (Rabeprazole Sulfide 4‐Methoxy Analog/ 4‐Desmethoxypropoxyl‐4‐Methoxy Rabeprazole
Sulfide) 102804‐82‐0
Rabeprazole EP Impurity H/Rabeprazole Related Compound F (Rabeprazole 4‐Chloro Analog/ Lansoprazole EP Impurity
F) 168167‐42‐8
Rabeprazole EP Impurity I (Rabeprazole Sulfone N‐Oxide) 924663‐37‐6
Rabeprazole EP Impurity K (Lansoprazole EP Impurity D) 615‐16‐7
4‐Desmethoxypropoxyl‐4‐Chloro Rabeprazole Sulfide (Lansoprazole EP Impurity F Sulfide/ Lansoprazole Sulfide 4‐Chloro
Analog) 103312‐62‐5
Rabeprazole 2‐Chloromethyl Impurity 153259‐31‐5
34.
Rabeprazole N‐Alkyl Impurity 935260‐92‐7
Rabeprazole Impurity 6
Rabeprazole S‐Isomer 171440‐19‐0
4‐chloro‐2‐(chloromethyl)‐3‐methylpyridine hydrochloride 152402‐97‐6
Rabeprazole 4‐Chloro Analog Sulfone 1159977‐27‐1
Rabeprazole Carboxylic Acid Impurity 1163685‐31‐1
Rabeprazole N‐Alkyl Sulfide 1114543‐47‐3
Rabeprazole N‐Alkyl Sulfone 1246818‐79‐0
Rabeprazole Sodium R‐Isomer 171440‐18‐9
Rabeprazole Sulfide N‐Oxide 924663‐40‐1
Rabeprazole Sulfonic Acid Impurity 40828‐54‐4
Product: RALOXIFENE IMPURITIES
Raloxifene EP Impurity C (Raloxifene N‐Oxide) 195454‐31‐0
Raloxifene Dimethoxy Impurity/ Raloxifene Bismethyl Ether 84541‐38‐8
2‐(4‐Hydroxyphenyl)benzothiophene‐6‐ol 63676‐22‐2
2‐(4‐Hydroxyphenyl)benzo[b]thiophen‐6‐ol Bimesylate 84449‐65‐0
1‐(2‐Chloroethyl)piperidine 2008‐75‐5
2‐(4‐Methoxyphenyl)benzo[b]thiophen‐6‐ol 225648‐21‐5
4‐(6‐Methoxybenzo[[]b]thiophen‐2‐yl)phenol 175460‐94‐3
Raloxifene Dimesylate
84541‐30‐0
84449‐85‐4
Raloxifene Benzoic Acid Impurity 84449‐80‐9
Product: RALTEGRAVIR IMPURITIES
Raltegravir EP Impurity G
Product: RAMIPRIL IMPURITIES
Ramipril EP Impurity A/ Ramipril Related Compund A (Ramipril Methyl Ester Analog) 108313‐11‐7
Ramipril EP Impurity B/ Ramipril Related Compund B (Ramipril Isopropyl Ester) 295328‐72‐2
Ramipril EP Impurity C/ Ramipril Related Compund C (Cyclohexyl Ramipril Analog) 99742‐35‐5
Ramipril EP Impurity D/ Ramipril Related Compund D (Ramipril Diketopiperazine) 108731‐95‐9
40.
Rivaroxaban Dioxazolidine Impurity
Rivaroxaban oxo amide impurity
Rivaroxaban Diamide
Rivaroxaban R‐Isomer (ent‐Rivaroxaban) 865479‐71‐6
Rivaroxaban amine dimer
(S)‐2‐(oxiran‐2‐ylmethyl)isoindoline‐1,3‐dione 161596‐47‐0
Rivaroxaban Aminomethyl Impurity 898543‐06‐1
(R)‐N‐Glycidylphthalimide 181140‐34‐1
2,3‐dihydrophthalazine‐1,4‐dione 1445‐69‐8
Rivaroxaban Diol 1160170‐00‐2
Rivaroxaban Phthalamide Dimer 1365267‐36‐2
3‐Chloro‐N‐[[(5S)‐2‐oxo‐3‐[4‐(3‐oxo‐4‐morpholinyl)phenyl]‐5‐oxazolidinyl]methyl]‐2‐thiophenecarboxamide 1855920‐54‐5
(R)‐4‐(4‐((3‐chloro‐2‐hydroxypropyl)amino)phenyl)morpholin‐3‐one 1252018‐10‐2
N,N’‐Dimethylphthalamide 19532‐98‐0
2,2'‐[[[4‐(3‐Oxo‐4‐morpholinyl)phenyl]imino]bis[(2R)‐2‐hydroxy‐3,1‐propanediyl]]bis[1H‐isoindole‐1,3(2H)‐dione] 1643354‐27‐1
Product: RIVASTIGMINE IMPURITIES
Rivastigmine EP Impurity A/ Rivastigmine Related Compound C (Rivastigmine Phenol Impurity) 139306‐10‐8
Rivastigmine EP Impurity B/ Rivastigmine Related Compound B (N‐Desethyl N‐Methyl Rivastigmine)
25081‐93‐0
1230021‐28‐9
105601‐13‐6
Rivastigmine EP Impurity C/ Rivastigmine Related Compound D 855300‐09‐3
Rivastigmine EP Impurity D (Rivastigmine R‐Isomer) 415973‐05‐6
Rivastigmine EP Impurity E 923035‐05‐6
Rivastigmine Related Compound F 1346602‐84‐3
Rivastigmine Desmethyl Impurity(Rivastigmine Impurity 3) 948051‐93‐2
Rivastigmine Desmethyl Impurity(Rivastigmine Impurity 2) 1070660‐34‐2
Rivastigmine Benzyl Impurity 1111083‐50‐1
Rivastigmine N‐Oxide 1369779‐37‐2
Rivastigmine p‐Hydroxy Impurity 1390639‐31‐2
41.
Rivastigmine o‐Hydroxy Impurity
Rivastigmine p‐Keto Impurity 1390639‐30‐1
Rivastigmine o‐Keto Impurity 2020035‐51‐0
1‐(3‐Aminophenyl)ethanol 2454‐37‐7
1‐(3‐Nitrophenyl)ethanol 5400‐78‐2
Rivastigmine Diethyl Analog 1230021‐34‐7
Rivastigmine Dihydroxy Phenyl Ether Impurity 893750‐82‐8
Rivastigmine DiKeto Phenyl Ether Impurity 94751‐95‐8
3‐((Dimethylamino)methyl)‐N,N‐dimethylaniline 179676‐15‐4
3‐(Dimethylamino)‐N,N‐dimethylbenzeneethanamine 106274‐78‐6
Rivastigmine Chloro Impurity 1390639‐33‐4
Rivastigmine Urea Impurity 31468‐19‐6
Rivastigmine Phenyl Mesylate
Ortho Isomer Of Rivastigmine
Para Isomer Of Rivastigmine
1,1'‐(oxybis(3,1‐phenylene))bis(N,N‐dimthylethanamine)/ Rivastigmine Diaryl Ether Impurity
3‐(1‐Hydroxyethyl)phenyl ethyl(methyl)carbamate 1222073‐98‐4
Rivastigmine Carbamate Impurity 1346242‐31‐6
3‐(1‐dimethylaminoethyl)phenol 105601‐04‐5
N‐Ethyl‐N‐methylcarbamoyl Chloride 42252‐34‐6
Product: RIZATRIPTAN IMPURITIES
Rizatriptan EP Impurity A
887001‐08‐3
1016900‐25‐6
Rizatriptan EP Impurity C (Iso Rizatriptan) 208941‐96‐2
Rizatriptan EP Impurity D
Rizatriptan EP Impurity F 160194‐39‐8
Rizatriptan EP Impurity G 1000673‐59‐5
Rizatriptan EP Impurity H (Rizatriptan N‐Oxide) 260435‐42‐5
Rizatriptan EP Impurity I (N‐Desmethyl Rizatriptan) 144034‐84‐4
Rizatriptan Hydrazone Impurity (Rizatriptan Impurity 1) 212248‐62‐9
42.
3‐Chloro‐1‐(N,N‐dimethyl)propylamine 5407‐04‐5
Product: ROCURONIUM IMPURITIES
Rocuronium EP Impurity C (17‐Desacetyl Rocuronium) 119302‐86‐2
Rocuronium EP Impurity F 1190105‐66‐8
4‐Amino‐3,5‐dichloropyridine N‐oxide 91872‐02‐5
Product: ROPINIROLE IMPURITIES
Ropinirole EP Impurity A/ Ropinirole Related Compound B (3‐Oxo Ropinirole)
221264‐21‐7
102842‐51‐3
Ropinirole EP Impurity B 249622‐60‐4
Ropinirole EP Impurity C/ Ropinirole Propylidene Impurity
221264‐43‐3
145570‐92‐9
Ropinirole EP Impurity D/ Ropinirole N‐Despropyl Impurity
106916‐16‐9
173990‐76‐6
Ropinirole EP Impurity E (3‐Methylene Ropinirole)
Ropinirole EP Impurity F/ Ropinirole Related Compound A 139122‐19‐3
Ropinirole EP Impurity H (3‐Hydroxyimino Ropinirole)
N‐Hydroxy Ropinirole Impurity
954117‐22‐7
1542267‐72‐0
Ropinirole N‐Oxide 1076199‐41‐1
Ropinirole Open Ring Amino Impurity 920755‐10‐8
Ropinirole N‐Ethyl Impurity 1797132‐03‐6
N‐(2‐methyl‐3‐nitrophenethyl)‐N‐propylpropan‐1‐amine 91374‐23‐1
ethyl 3‐(2‐(2‐(dipropylamino)ethyl)‐6‐nitrophenyl)‐2‐oxopropanoate 91374‐24‐2
Ropinirole Open Ring Nitro Impurity 91374‐25‐3
4‐Vinylindolin‐2‐one 120427‐93‐2
Ropinirole Methylene Dimer 1800102‐50‐4
4‐[2‐[[(4‐Methylphenyl)sulfonyl]oxy]ethyl]‐1,3‐dihydroindol‐2‐one 139122‐20‐6
Ropinirole Cyclopentanylindone Impurity 1368745‐05‐4
Ropinirole N‐Hydroxymethyl Impurity 1027600‐42‐5
Product: ROPIVACAINE IMPURITIES
43.
Ropivacaine EP Impurity H/ Ropivacaine Related Compound A (Lidocaine EP Impurity A/ Lidocaine Related Compound A/
Bupivacaine EP Impurity F/ Mepivacaine EP Impurity A)
87‐62‐7
21436‐98‐6
Ropivacaine N‐Oxide 1391053‐59‐0
Product: ROSIGLITAZONE IMPURITIES
Rosiglitazone Impurity A 1797979‐55‐5
5‐[4‐[2‐((Methyl)pyridin‐2‐ylamino)ethoxy]benzylidene]thiazolidine‐2,4‐dione 122320‐74‐5
Product: ROSUVASTATIN IMPURITIES
Rosuvastatin EP Impurity A/ Rosuvastatin Related Compound A
1715120‐13‐0
1714147‐50‐8
Rosuvastatin EP Impurity B 1094100‐06‐7
Rosuvastatin EP Impurity C (5‐Oxo Rosuvastatin/ 3‐Hydroxy‐5‐Keto Rosuvastatin)
1422619‐13‐3
1620823‐61‐1
Rosuvastatin EP Impurity D (Rosuvastatin (3R,5S)‐Lactone) 503610‐43‐3
Rosuvastatin EP Impurity F (Rosuvastatin Acetonide t‐Butyl Ester) 289042‐12‐2
Rosuvastatin EP Impurity G/ Rosuvastatin Related Compund D (Rosuvastatin Calcium Enantiomer/ enti‐Rosuvastatin/
Rosuvastatin (3S,5R)‐Isomer) 1242184‐42‐4
Rosuvastatin EP Impurity G t‐Butyl Ester (Rosuvastatin (3S,5R)‐Isomer t‐Butyl Ester) 615263‐60‐0
Rosuvastatin 6,7‐Dihydro Impurity
1347797‐73‐2
1347362‐67‐7
2,3‐Anhydro Rosuvastatin Calcium Salt/ Rosuvastatin 2,6‐Diene Impurity 1422954‐12‐8
Rosuvastatin 3‐Oxo Acid Ethyl Ester 901765‐36‐4
Rosuvastatin 4,6‐Diene Impurity/ 4,5‐Anhydro Rosuvastatin 1346606‐44‐7
Rosuvastatin (6R)‐Lactone Impurity 854898‐46‐7
Rosuvastatin (6S)‐Lactone Impurity 854898‐47‐8
3‐Oxo Rosuvastatin
1346747‐49‐6
1346606‐28‐7
Rosuvastatin N‐Desmethyl Impurity 371775‐74‐5
Rosuvastatin (6S)‐Isomer 854898‐53‐6
Rosuvastatin Methyl Ester 147118‐40‐9
44.
Product: ROXITHROMYCIN IMPURITIES
Roxithromycin EP Impurity A (Erythromycin A) 114‐07‐8
Roxithromycin EP Impurity B (Dicladinosyl Roxithomycin) 214902‐82‐6
Roxithromycin EP Impurity C (Erythromycin Oxime/ Azithromycin Impurity S/ 9‐Erythromycin A Oxime/ Clarithromycin
EP Impurity J) 13127‐18‐9
Roxithromycin EP Impurity D ((Z)‐Roxithromycin/ Erythromycin 9‐(Z)‐[O‐[(2‐Methoxyethoxy)methyl]‐oxime]) 134931-00-3
Roxithromycin EP Impurity F (N‐Demethyl Roxithromycin) 118267‐18‐8
Product: RUFINAMIDE IMPURITIES
Rufinamide Related Compound B (Rufinamide Methyl Ester Analog) 217448‐86‐7
Rufinamide acid impurity 166196‐11‐8
Product: RUPATADINE IMPURITIES
Rupatadine impurity B 100643‐71‐8
Rupatadine Impurity F 102074‐19‐1
Product: SACUBITRIL IMPURITIES
Sacubitril N‐Boc Ester 149709‐60‐4
Sacubitril Amine Acid 1038924‐71‐8
Sacubitril (3R,5S)‐Pyrrolidinone Impurity 1038924‐70‐7
Diacid of Sacubitril/ Sacubitril Desethyl Impurity/ Sacubitrilat 149709‐44‐4
Sacubitril 2,5‐Dioxopyrrolidine 1038924‐97‐8
Sacubitril Maleic acid
Sacubitril Methyl ester
(2R,4S)‐methyl 5‐([1,1'‐biphenyl]‐4‐yl)‐4‐amino‐2‐methylpentanoate hydrochloride 1933501‐50‐8
(2R,4S)‐4‐Amino‐5‐(biphenyl‐4‐yl)‐2‐methylpentanoic Acid Ethyl Ester Hydrochloride 149690‐12‐0
(2R,4S)‐ethyl 5‐([1,1‐biphenyl]‐4‐yl)‐4‐acetamido‐2‐methylpentanoate
(2R,4S)‐5‐(Biphenyl‐4‐yl)‐4‐[(tert‐butoxycarbonyl)amino]‐2‐methylpentanoic Acid 1012341‐50‐2
Product: SAFINAMIDE IMPURITIES
(S)‐2‐[[3‐(3‐Fluorobenzyl)‐4‐[(3‐fluorobenzyl)oxy]benzyl]amino]propanamide 1000370‐27‐3
3‐(3‐Fluorobenzyl)‐4‐[(3‐fluorobenzyl)oxy]benzaldehyde 1000370‐24‐0
4‐[(3‐Fluorobenzyl)oxy]benzoic Acid 405‐85‐6
45.
Product: SALBUTAMOL IMPURITIES
Salbutamol EP Impurity A (Salbutamol Methyl Ether/ Levalbuterol Related Compound H) 870076‐72‐5
Salbutamol EP Impurity B (Salbutamol Deshydroxymethyl Impurity/ t‐Butylnorsynephrine) 96948‐64‐0
Salbutamol EP Impurity C (2‐Deshydroxy Salbutamol/ Albuterol Related Compound A/ Levalbuterol Related Compound
B) 18910‐68‐4
Salbutamol EP Impurity D (Salbutamol Aldehyde Impurity/ Levalbuterol Related Compound D) 156339‐88‐7
Salbutamol EP Impurity E (N‐Benzyl Albuterol) 24085‐03‐8
Salbutamol EP Impurity F (Salbutamol Dimer Ether/ Albuterol Related Compound E) 147663‐30‐7
Salbutamol EP Impurity G (N‐Benzyl Salbutamone)
64092‐10‐0
24085‐08‐3
Salbutamol EP Impurity H (Salbutamol Dideshydroxy Impurity) 132183‐64‐3
Salbutamol EP Impurity I (4‐Benzyl Albuterol) 56796‐66‐8
Salbutamol EP Impurity J (Albuterol Related Compound B)
156547‐62‐5
41489‐89‐8
Salbutamol EP Impurity K 898542‐80‐8
Salbutamol EP Impurity L 898542‐81‐9
Salbutamol EP Impurity M 18910‐70‐8
Salbutamol EP Impurity N (Albuterol Dimer) 149222‐15‐1
Salbutamol Ethyl Ether (Albuterol Related Compound F) 1221742‐55‐7
Salbutamol Diethyl Ether 1221726‐71‐1
Salbutamol Glyoxal Impurity 72189‐44‐7
5‐Hydroxy Salbutamol 182676‐90‐0
(±)‐4‐O‐Ethyl Albuterol
(±)‐4‐O‐Ethyl Salbutamol
Methyl 5‐acetyl‐2‐hydroxybenzoate 16475‐90‐4
Methyl 5‐acetyl‐2‐ethoxybenzoate 39971‐36‐3
Methyl 5‐(2‐bromoacetyl)‐2‐ethoxybenzoate 24085‐34‐5
Product: SALMETEROL IMPURITIES
Salmeterol EP Impurity A/ Salmeterol Related Compound A 1798014‐51‐3
Salmeterol EP Impurity B/ Salmeterol Phenylethoxy Impurity 94749‐02‐7